This study tests the drug cabozantinib in 50 adults with germ cell tumors (like testicular or ovarian cancer) that have stopped responding to standard chemotherapy. The goal is to see if the drug can shrink tumors or keep them stable for at least 3 months. Participants take caboz…
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Jun 17, 2026 04:13 UTC